These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8817892)

  • 1. Multicomponent acoustic distortion product otoacoustic emission phase in humans. II. Implications for distortion product otoacoustic emissions generation.
    Moulin A; Kemp DT
    J Acoust Soc Am; 1996 Sep; 100(3):1640-62. PubMed ID: 8817892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. II. Interrelations between multicomponent DPOAEs, tone-burst-evoked OAEs, and spontaneous OAEs.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1471-86. PubMed ID: 10738802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicomponent acoustic distortion product otoacoustic emission phase in humans. I. General characteristics.
    Moulin A; Kemp DT
    J Acoust Soc Am; 1996 Sep; 100(3):1617-39. PubMed ID: 8817891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group delays of distortion product otoacoustic emissions in the guinea pig.
    Schneider S; Prijs VF; Schoonhoven R
    J Acoust Soc Am; 1999 May; 105(5):2722-30. PubMed ID: 10335624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locus of generation for the 2f1-f2 vs 2f2-f1 distortion-product otoacoustic emissions in normal-hearing humans revealed by suppression tuning, onset latencies, and amplitude correlations.
    Martin GK; Jassir D; Stagner BB; Whitehead ML; Lonsbury-Martin BL
    J Acoust Soc Am; 1998 Apr; 103(4):1957-71. PubMed ID: 9566319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications of different distortion product otoacoustic emission mechanisms from a detailed f1,f2 area study.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2000 Jan; 107(1):457-73. PubMed ID: 10641654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase delay measurements of distortion product otoacoustic emissions at 2f1-f2 and 2f2-f1 in human ears.
    Wable J; Collet L; Chéry-Croze S
    J Acoust Soc Am; 1996 Oct; 100(4 Pt 1):2228-35. PubMed ID: 8865631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group delays of distortion product otoacoustic emissions: relating delays measured with f1- and f2-sweep paradigms.
    Prijs VF; Schneider S; Schoonhoven R
    J Acoust Soc Am; 2000 Jun; 107(6):3298-307. PubMed ID: 10875375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative distortion product otoacoustic emissions and hearing loss in a clinical population.
    Lind O
    Scand Audiol; 1999; 28(4):257-61. PubMed ID: 10572971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the 2f
    Wen H; Bowling T; Meaud J
    Hear Res; 2018 Aug; 365():127-140. PubMed ID: 29801982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of generation of the 2f2-f1 distortion product otoacoustic emission in humans.
    Wilson HK; Lutman ME
    J Acoust Soc Am; 2006 Oct; 120(4):2108-15. PubMed ID: 17069308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parameters to maximize 2f2-f1 distortion product otoacoustic emission levels.
    Horn JH; Pratt SR; Durrant JD
    J Speech Lang Hear Res; 2008 Dec; 51(6):1620-9. PubMed ID: 18664689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of the onset of distortion-product otoacoustic emissions, and measurement of their latency.
    Whitehead ML; Stagner BB; Martin GK; Lonsbury-Martin BL
    J Acoust Soc Am; 1996 Sep; 100(3):1663-79. PubMed ID: 8817893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2f1-f2 distortion product otoacoustic emission latency: changes with frequency and level of primaries.
    Wable J; Collet L; Berger-Vachon C; Chéry-Croze S
    Audiology; 1997; 36(2):72-82. PubMed ID: 9099405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion Product Otoacoustic Emissions in Mice Above and Below the Eliciting Primaries.
    Cheatham MA
    J Assoc Res Otolaryngol; 2023 Aug; 24(4):413-428. PubMed ID: 37464091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emission (2f1-f2) amplitude as a function of f2/f1 frequency ratio and primary tone level separation in human adults and neonates.
    Abdala C
    J Acoust Soc Am; 1996 Dec; 100(6):3726-40. PubMed ID: 8969474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wave and place fixed DPOAE maps of the human ear.
    Knight RD; Kemp DT
    J Acoust Soc Am; 2001 Apr; 109(4):1513-25. PubMed ID: 11325123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for the distortion product frequency place as a source of distortion product otoacoustic emission (DPOAE) fine structure in humans. I. Fine structure and higher-order DPOAE as a function of the frequency ratio f2/f1.
    Mauermann M; Uppenkamp S; van Hengel PW; Kollmeier B
    J Acoust Soc Am; 1999 Dec; 106(6):3473-83. PubMed ID: 10615687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of primary frequencies ratio on distortion product otoacoustic emissions amplitude. I. Intersubject variability and consequences on the DPOAE-gram.
    Moulin A
    J Acoust Soc Am; 2000 Mar; 107(3):1460-70. PubMed ID: 10738801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.